Why wouldn’t you comment on what they think? Selling to them has always been the goal. I’m trying to work out if anyone at RAC actually knows and is tailoring the plan to it.
The one person that was transparent about fitting BP pipeline, got moved on pretty quickly (resigned)
I’m just so unsure and confused how you & team could design a strategy around EMD & 18 months later acknowledge it had no commercial future, what? I don’t care the trial didn’t go ahead, I care it even got that far in the first place and your now CEO. That baffles me.
I know you sought out and spoke to clinician's prior, and then the reality ended up being different. Which is to my point, why is this time different?
General Comments / Chat, page-9530
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.030(2.11%) |
Mkt cap ! $247.1M | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.45 | $1.40 | $163.8K | 115.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 31396 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |